Tumor Inhibition: According to the study, when compared to the ESC control group, all treatments caused noticeably higher necrosis in the tumor cells.Immunological Response: According to immunohistochemistry analysis, CP therapy increased the number of CD8+ T cells and decreased the number of Treg cells, raising the CD8+/Treg cell ratio surrounding the tumor. This evidence concerns the gene CP and neoplasm.